GO Therapeutics

One Broadway
Cambridge
Massachusetts
02142
United States

Email: info@gotherapeutics.com

Show jobs for this employer

About GO Therapeutics

GO Therapeutics is applying the latest advances in glycobiology to create cancer drugs that are more potent and less toxic. GO Therapeutics’ cancer specific antibodies against tumor-specific antigens can be used in a multimodal approach to killing cancer, such as antibody-drug-conjugates, bi-specific T-cell engagers and immune-based cell therapies. The company’s scientific team includes some of the leading scientific researchers and applied biologists in glycoproteomics. GO Therapeutics is based in Cambridge, MA.
LEADERSHIP:
Founder and CEO: Constantine Therodoropulos
Founder and CSO: Thayer White
CLINICAL TRIAL:
Please click here for clinical trial information.

3 articles with GO Therapeutics